
Transactions: Sweden
Filter


Divestment of Swedish Orphan International AB (SE) to Investor Growth Capital (SE) and Skandia Investment (SE) — Amount not disclosed.

New share issue in Biotage AB (SE) — SEK 97 million

Directed new share issue in BioInvent International (SE) — SEK 136 million

Divestment of Telia’s (SE) commercial property portfolio — SEK 5.1 billion

Redemption offer in JM (SE) — SEK 1 billion

Secondary placing of 5.7 million shares in Intrum Justitia (SE) — EUR 35 million

Convertible rights issue in Elekta (SE) — SEK 467 million

Initial public offering of BioInvent International AB (SE) — SEK 372 million

Divestment of Entific Medical Systems (SE) to Cochlear (AU) by CapMan, Investor Growth Capital and Nobel Biocare (SE) — SEK 1,050 million

New share issue in Biotage AB (SE) — SEK 34 million
